Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.375p +0.63% 59.50p 58.50p 59.50p 59.50p 58.75p 58.75p 223,853 13:17:54
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 97.5 22.2 3.9 15.5 281.41

Alliance Pharma Share Discussion Threads

Showing 1451 to 1473 of 1475 messages
Chat Pages: 59  58  57  56  55  54  53  52  51  50  49  48  Older
DateSubjectAuthorDiscuss
14/11/2017
12:55
Modest correction today, man this is a boring holding :/
rathean
04/11/2017
10:30
I'm expecting pharma consolidation to ramp up before your 5 years is out, although I suspect Alliance will be buying and not bought
rathean
03/11/2017
17:55
Finally on the move? Just checked my records and I bought my first 10K's worth 8th Nov 2010 at 38.5p. Hardly a stellar rise, but perhaps the next 5 years will be interesting.
2vdm
03/11/2017
17:32
Nice tick up today, hopefully it can hold above 60
rathean
31/10/2017
14:39
Some strong momentum is starting to build
reynoldsg
31/10/2017
11:37
I see it as a 5 to 10 year play, but expect it to be swallowed up long before then.
dozey3
31/10/2017
11:20
Tickling 60 again, damn teaser...
rathean
27/10/2017
12:39
This clearly has buying support. Very stable share price in the absence of news. A break of 60p sets a target of 80p - 400M Mcap.
petethehippy
27/10/2017
10:58
I bought also as a steady as it goes dependable growth share to balance out the more risky plays. Think you need some of those. Warren Buffet has this mindset; steady as she goes and compound your investments. Over time you should do well with this strategy, but then some want quick profits and go for more risky things.
armunro
20/9/2017
20:51
http://www.stockopedia.com/content/sif-portfolio-alliance-pharma-could-be-the-defensive-prescription-i-need-220738/
norbert colon
19/9/2017
10:45
I have held APH for a long time, first (after a company visit)with the Loan Notes and then, on conversion, the Ordinaries. I regard it as steady share which doesn't need much attention. I think that the share price hasn't sparkled because of several factors, • There isn't a story which can excite commentators or investors. They seem to buy things here and there when cash flow allows. Admittedly they did use shares for the Sinclair deal but all this did was reduce the price. • By comparison, I also hold shares in two similar companies, Clinigen and Venture Life. CLIN is acquisitive but has a clear story to tell and a price to match. VLG is a newcomer on a similar path and does trade with APH in a small way. • APH's record so far has not excited and the problem with keeping on spending hard earned cash on acquisitions is that the intangibles dominate the balance sheet. Shareholders' Equity is shown as £187m (market cap £250m) but this includes £263m of intangibles. As far as I can establish, if a product line doesn't perform, they don't write off the associated Goodwill, they just assume that if profits are going up there is no need for an impairment charge. What happens if a major product goes off the boil? • I have argued that the company, being low growth, should be more investor friendly and pay a higher dividend that they could well afford. This would help the share price but John Dawson doesn't want to play it that way. • What is ignored by investors (because it is obscured by the constant outflow on acquisitions) is the fantastic cash flow. Mind you, even if they stopped acquiring, it would still take many years to recover the intangibles. Why do I continue to hold? Inertia partly. I did sell a good chunk at 59.5p when the opportunity arose a couple of years ago and I think patience will see us back over that level - 'When?' I hear you ask.
123prezzie
13/9/2017
14:35
https://uk.finance.yahoo.com/news/2-cheap-stocks-d-buy-134625470.html?.tsrc=applewfRated as a buy here. Hopefully tick upwards towards 60p. LTH.
gamwah
13/9/2017
11:17
2vdm: perhaps the word you are looking for is "cart-horse" Been on my watch list for ages but cannot see significant capital appreciation but probably better overall yield than cash in a savings account.
pugugly
13/9/2017
11:12
Interims show good solid progress,increased profits, M@shield doing well, loans reducing and a healthy cash position. The only surprise for me is that there seems to be little interest shown. I'm just going to keep adding as I think this is well under the radar. It's not a racehorse, but jogs along and in the right direction. Well done to the mngt. and I look fwd to news during H2.
2vdm
30/8/2017
17:04
Interims due for 6 months to 30th June to be announced on 13th September, so unless N Korea causes chaos, we should see increased interest here.
2vdm
31/7/2017
07:47
The timing of such news is always going to be difficult, however 9 mins before close (16.21hrs) on last day of the week certainly 'leaves a bad taste'. APH's BoD will need to consider more transparency on the timetable leading up to this announcement to retain credibility. Regulatory Approval for any of their products (or disapproval) is a matter of some significance to share price value. Particularly when not long ago APH was anticipating £250mln 'potential sales of Diclectin across UK/European market with a differentiated product addressing an unmet need.' For details, see: http://tinyurl.com/y7ahl4qa
mazarin
28/7/2017
22:23
Diclectin works-but is controversial-not allowed in many countries but widely used in Canada I think for years which surprises me that the MHRA even agreed to accept it for review, in which case i would have expected them to pass it as much of the clinical data is in the public domain so it may be a technical issue, ? marketing-esp as aimed at pregnant women so particularly sensitive area. Could be double edged sword for APH if accepted-big demand-no real alternatives save remedies like vitamins etc but wonder if NICE had input and got cold feet-everyone remembers Thalidomide- and diclectin has been the subject of numerous lawsuits in past I believe so maybe not a major loss for APH. Presume more info will come out from APH-this evenings was clearly rushed before market close. Whoever bought shares at 55p during week-had to be II who wont be happy if APH had inkling of news or there was a leak from MHRA which went to certain big holders (in which case huge mgmt repercussions) but I doubt if anyone knew. Aimo-dyor
cumnor
28/7/2017
22:03
Cisk, I also thought it was a marketing issue when I read the rns however after looking into it I think it may be that there is no proof that it actually works...if that is the case then it's serious. hxxp://www.ctvnews.ca/mobile/health/medical-journal-no-longer-recommends-popular-morning-sickness-pill-1.3258690
blindsquirrel
28/7/2017
21:46
Reading the rns it says the marketing submission has been rejected, presumably not the product? So aph need to submit revised marketing text for the product? Apologies if it's more complex than this. I'm sure bank of can and wray were unaware of this - wray still owns a fair chunk. Would be interesting to find out exactly when the company got this news though...
cisk
28/7/2017
16:14
How we know why Nigel Wray; sold a large chuck of his holding. Disappointed with this company's actions.
williamgtheobald
28/7/2017
16:12
Me to, I sold around 50p a while back and thought I'd missed the boat. Oh how things change, if it does go back to the 40's I could be interested again.
buying
28/7/2017
16:01
Yeah me too sold mine, bank of canada sold recently!
rolo7
28/7/2017
15:59
I thought better of this company than to issue an RNS at 4.20. I wonder if it will drift into the mid 40's
buying
Chat Pages: 59  58  57  56  55  54  53  52  51  50  49  48  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20171121 14:11:38